Respiratory

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Immunization, Infectious Disease, Pulmonology

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunology, Pulmonology

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Pulmonology

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

More News

February 20th 2022

Small Study Shows 100% Success in Lung Transplants for COVID-19–Associated ARDS

Survival was 100% among patients who had COVID-19-associated acute respiratory distress syndrome (ARDS), and 83% for those without COVID-19 infection.

Patsy Stinchfield, RN, MS, and William Schaffner, MD

February 16th 2022

NFID Board Members Discuss COVID-19's Impact on RSV Seasonality

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how the COVID-19 pandemic has had an impact on the seasonality of respiratory syncytial virus (RSV).

February 14th 2022

Shorter Treatment for Community-Acquired Pneumonia as Effective as Longer Course

Research suggests a shorter 5-day antibiotic regimen for childhood community-acquired pneumonia, instead of 10 days, can optimize treatment efficacy while reducing unnecessary antibiotic use.

Nurse and patient walking in hospital hallway

February 5th 2022

Study Finds Higher In-Hospital Mortality Risk for Older Patients With Frailty, COVID-19

Research showed that younger and nonfrail patients with COVID-19 were more likely to be put on a ventilator, while patients with frailty and older age had a higher risk of in-hospital and in-ICU mortality.

February 4th 2022

Controversial Paper Claims COVID-19 "Lockdowns" Had Little Public Health Effect

A meta-analysis from 3 economists concluded that nonpharmaceutical interventions in response to COVID-19 failed to have a large, significant effect on mortality rates.

February 3rd 2022

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Jessica K. Costales-Cantrell, DO, MBS Joanie Chung, MPH Jim H. Nomura, MD Kristen R. Ironside, MS Paul W. Salama, MD John J. Sim, MD

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.

February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.

January 27th 2022

Review Evaluates Factors of Pulmonary Disease Subtype Development

The review discussed the roles of sex, ancestry, senescence, and aging in the development of nontuberculous mycobacterial pulmonary disease.

January 26th 2022

What We’re Reading: Long-term COVID-19 Factors; Rhode Island Joins Opioid Settlement Case; EPA and "Cancer Alley"

A study found 4 factors may correlate with increased risk of long-term COVID-19; Rhode Island joins opioid settlement against McKesson, AmerisourceBergen, and Cardinal Health; the Environmental Protection Agency announced it will station mobile equipment in Louisiana to measure air pollution.

January 25th 2022

What We're Reading: Ineffective COVID-19 Drugs; Panel Advises Fourth Dose in Israel; Physician Mental Health Amid Pandemic

FDA significantly restricts the use of 2 COVID-19 monoclonal antibody treatments ineffective against the Omicron variant; an expert panel advises the Israeli government to offer a fourth COVID-19 vaccine dose to adults; there was a substantial increase in visits for mental health and substance abuse among physicians with no prior history during the pandemic.

January 19th 2022

Study Highlights Health, Economic Benefits of RSV Vaccine for Older Adults

With no existing respiratory syncytial virus (RSV) vaccine yet, researchers found that a vaccine comparable with the influenza vaccine could prevent tens of thousands of hospitalizations and deaths per year.

January 14th 2022

UK Study Characterizes Patient, Health Care System Burden From Chronic Cough

Rose McNulty

Chronic cough can have a significant impact on patient quality of life, and recognizing it as an individual condition may help optimize its treatment.

January 7th 2022

CDC Clarifies New COVID-19 Isolation Protocol, Outlines Efforts to Protect Children

Gianna Melillo

CDC officials clarified the agency's new isolation recommendations for individuals infected with COVID-19 and provided updates on its efforts to reduce pediatric cases among those too young to receive vaccines.

January 5th 2022

What We’re Reading: US Increases Pfizer Pill Order; California At-Home STI Tests; Supreme Court Hearing on Vaccine Mandates

The Biden administration doubled its order of Pfizer’s COVID-19 antiviral drug; California is now the first state to require health insurance plans to cover at-home STI tests; the Supreme Court will hear in-person arguments Friday to decide whether to block federal vaccine mandates.

December 29th 2021

Top 5 Respiratory Content of 2021

An 8-year journey to a chronic cough diagnosis, neurogenic cough treatment, e-cigarettes, and COVID-19 risk factors were among the most-viewed respiratory articles.

December 26th 2021

Dr Laurie Slovarp on the Importance of Early Behavioral Cough Therapy

Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.

Timothy C.Pigg, president and CEO, Rotech Healthcare Inc

December 23rd 2021

Contributor: Objective Documentation Protects Patient Access to Home Oxygen Therapy

Timothy C. Pigg

Facing the challenges created by the COVID-19 pandemic, the US medical community has been forced to rapidly change and modernize the manner in which it delivers health care over the last year-and-a-half.

December 23rd 2021

A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021

Although 2021 closes with a plentiful supply of COVID-19 vaccines and boosters, Americans continue to face challenges with the widespread Omicron variant and new testing hurdles.

December 19th 2021

Dr Laurie Slovarp on Preventing and Suppressing Chronic Cough Events

Most people are aware of what triggers their chronic cough and how to temporarily suppress it, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.

December 17th 2021

FDA Approves Tezepelumab for Severe Asthma

Allison Inserro

December 12th 2021

Dr Laurie Slovarp Explains How Chronic Cough Impacts Quality of Life

Chronic cough can be very debilitating to a patient's quality of life, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.

December 10th 2021

Asthma Education Linked to Better 1-Year Disease Control Outcomes in Adolescents, Study Finds

Participation in education sessions and frequent web-based monitoring predicted 1-year outcomes of asthma control for adolescents with partly controlled and uncontrolled asthma.

December 6th 2021

COVID-19 Not Creating Lingering Chronic Cough Impacts, Dr Peter Dicpinigaitis Says

Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.

December 3rd 2021

TENS Has Potential as a Treatment for Chronic Cough, Small Study Finds

A small study found that patients with chronic cough saw improvements in symptoms following transcutaneous electrical nerve stimulation treatment, with minimal adverse effects.

December 2nd 2021

FeNO Values Linked to ICS Therapy Response Rates in Patients With Chronic Cough

A systematic review showed that a high fractional exhaled nitric oxide (FeNO) value before starting inhaled corticosteroid (ICS) therapy may be associated with higher response rates in patients with chronic cough.

November 27th 2021

Potential Markers of COVID-19 Severity Found Among Patients With Chronic Airway Diseases

Gianna Melillo

Results of a retrospective study revealed potential markers of COVID-19 severity among those with chronic obstructive pulmonary disease, asthma, or chronic bronchitis.

November 24th 2021

Heartburn Can Predict Acid Suppression Success in Chronic Cough, Study Finds

Despite a relatively low response rate to acid suppression therapy to treat chronic cough, heartburn was a highly significant predictor of success.

November 20th 2021

Poor Nutritional Status May Predict High Pneumonia Risk in Elderly, Study Finds

The prognosis was worse in patients with basic dementia or Alzheimers disease as well as chronic obstructive pulmonary disease or asthma.

November 19th 2021

Bronchial Hyperresponsiveness May Predict Cough-Variant Asthma in Adults With Chronic Cough